Literature DB >> 15806036

Genetics and the variability of treatment response in asthma.

Elliot Israel1.   

Abstract

Pharmacogenetics is the study of how genetic differences influence the variability in patients' responses to therapy. Using specific examples in asthma, I will define the concepts of variability in response to therapy in asthma. I will then use the relationship between specific genetic polymorphisms and the response to beta-adrenergic agonists and leukotriene modifiers to illustrate pharmacogenetic interactions and to acquaint the reader with the applicability of these findings to clinical practice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15806036     DOI: 10.1016/j.jaci.2005.01.029

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

1.  Monitoring asthma control using claims data and patient-reported outcomes measures.

Authors:  Tom James; Michael Fine
Journal:  P T       Date:  2008-08

Review 2.  G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspective.

Authors:  Miles D Thompson; Jun Takasaki; Valérie Capra; G Enrico Rovati; Kathy A Siminovitch; W McIntyre Burnham; Thomas J Hudson; Yohan Bossé; David E C Cole
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study.

Authors:  Jill M Ferdinands; David M Mannino; Marta L Gwinn; Molly S Bray
Journal:  PLoS One       Date:  2007-03-14       Impact factor: 3.240

4.  Towards precision drug therapy in asthma.

Authors:  Job F M van Boven
Journal:  Ann Transl Med       Date:  2022-09

5.  Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist.

Authors:  James P Kemp
Journal:  Ther Clin Risk Manag       Date:  2009       Impact factor: 2.423

6.  In vitro allergen challenge of peripheral blood induces differential gene expression in mononuclear cells of asthmatic patients: inhibition of cytosolic phospholipase A2alpha overcomes the asthma-associated response.

Authors:  K A Whalen; H Legault; C Hang; A Hill; M Kasaian; D Donaldson; G W Bensch; G Bensch; J Baker; P S Reddy; N Wood; M K Ramarao; D K Ellis; C Csimma; C McKee; J D Clark; J Ryan; A J Dorner; M O'Toole
Journal:  Clin Exp Allergy       Date:  2008-07-28       Impact factor: 5.018

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.